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issection of
he Descending Thoracic Aorta
ooking Into the Future*
ric M. Isselbacher, MD, FACC
oston, Massachusetts
n this issue of the Journal, Song et al. (1) report a retrospective
nalysis of the midterm outcomes of 100 patients with an acute
ortic dissection involving the descending thoracic aorta. Of
he 100, 51 had a DeBakey type I (involvement of both the
scending and descending thoracic aorta) aortic dissection and
nderwent early repair of the ascending thoracic aorta, and 49
ad a DeBakey type III (no involvement of the ascending
orta) aortic dissection. The subjects were followed longitudi-
ally with serial computed tomography (CT) scans for a mean
f 31 months, and were followed clinically for a mean of 53
onths. Among a subset of 53 subjects who had aortic
maging repeated beyond 2 years, an aortic aneurysm devel-
ped in 28%, with the majority of aneurysms involving the
roximal segment of the descending thoracic aorta. The
roximal segment also grew most rapidly, at rate of 3.4  3.6
m/year. There was a trend toward slightly faster rates of
ortic growth among those with type I versus type III dissec-
ion, at 3.8  3.5 mm/year versus 3.1  3.1 mm/year,
espectively.
See page 799
The authors measured both total aortic diameter and the
iameter of the false lumen alone at multiple levels in the
orta. Although overall aortic diameter was a predictor of
ortic aneurysm formation, it was not found to be an
ndependent predictor on multivariate analysis. Instead,
hey found that Marfan syndrome and large false lumen
iameters at the upper and mid-descending thoracic aorta
ere independent predictors of late aneurysm formation.
ividing their populations into those with a small false
umen diameter (21 mm) and those with a large false
umen diameter (22 mm) in the upper descending thoracic
orta, they demonstrated that those with a large false lumen
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.f
From the Thoracic Aortic Center and Cardiology Division, Massachusetts General
ospital, Boston, Massachusetts.ad a markedly greater risk of late aneurysm formation (42%
s. 5%, p  0.001), with a trend toward increased mortality
17% vs. 5%, p  0.09) as well.
So why are these findings so important? To put these
ndings into clinical perspective, it is best to step back and
onsider our current understanding of the management and
utcome of distal aortic dissection.
It is well established that those with aortic dissection
nvolving the ascending thoracic aorta (DeBakey types I and
I, or Stanford type A) are at high risk of early death, as the
issected ascending aorta has a propensity to rupture into
he pericardial space. Consequently, such patients are man-
ged with early surgical repair of the ascending thoracic
orta, as decades of data have validated the advantage of
urgery over medical therapy for this group.
Conversely, those with aortic dissections involving the
escending aorta but not the ascending aorta (DeBakey type
II, Stanford type B) have a relatively low risk of aortic
upture and, thus, have a significantly lower early mortality.
oreover, surgery to repair the descending thoracic aorta in
his setting is associated with substantial mortality and
orbidity, including the dreaded complication of paraple-
ia. Therefore, since surgery was shown to confer no
urvival advantage over medical therapy for uncomplicated
ype III aortic dissection, medical therapy became (2), and
emains, the treatment of choice. Early surgery to repair the
escending thoracic or abdominal aorta is, in turn, reserved
or those patients in whom vascular complications of dis-
ection (rupture, malperfusion syndromes, and so on) arise.
But even when patients survive an acute aortic dissection,
hey remain at long-term risk of midterm and late aortic
omplications (i.e., aortic aneurysm formation, aortic rup-
ure, extension or recurrence of dissection) and death. This
pplies to both those with unrepaired type III aortic
issection and those with type I aortic dissection who have
ndergone successful ascending aortic repair but have per-
istent dissection of the distal aortic segments; in essence,
fter ascending aortic repair, the type I aortic dissection
ecomes anatomically equivalent to a type III aortic dissec-
ion. Nevertheless, the long-term outcomes of aortic dissec-
ion remain somewhat poorly defined. Challenges in assess-
ng risk have included the relatively low numbers of patients
n single centers, marked variations in aortic anatomy
mong dissection patients, the age and comorbidities of the
issection population, and the fact that both treatments and
maging techniques are rapidly evolving. Indeed, whereas
nce patients with chronic aortic dissection were followed
ith serial chest radiography, we now have readily available
piral CT scanning that permits close surveillance of aortic
natomy. Moreover, in the last 2 decades, we have seen the
ore consistent and aggressive use of long-term anti-
mpulse and antihypertensive therapies in these patients.
Not surprisingly, then, the modern prognosis for survi-
ors of acute aortic dissection appears to be somewhat more
avorable than in historical reports. For example, in a series
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Editorial Comment August 21, 2007:805–7f patients with repaired type I aortic dissection, survival
ates were 78% at 5 years and 66% at 10 years, compared
ith approximately 93% and 80%, respectively, for an age-
nd gender-matched control population (3). With regard to
edically managed type III aortic dissection, in the experi-
nce of the International Registry of Acute Aortic Dissec-
ion (IRAD), the 3-year survival was 77% (4). Alternatively,
n a prospective study, medically managed acute type III
ortic dissection in Sweden, the 10-year survival was higher
t 82% at 5 years and 69% at 10 years, and only slightly
elow that of the age- and gender-matched general popu-
ation, and most of the patients actually died of causes
nrelated to their dissections (5).
Given the reasonable outcomes associated with chronic
istal aortic dissections, there seems little reason to revisit
he role of prophylactic “open” surgery to prevent the
otential late complications of dissection. However, the last
ecade has witnessed remarkable advances in minimally
nvasive approaches to repair of distal aortic dissection using
ndovascular stent-graft techniques. After reports in 1999 of
he successful endovascular stent-grafting repair of both
cute, complicated (6) and chronic, stable (7) type III aortic
issections, the technique has become used more and more
idely in place of open surgery for the treatment of the
ascular complications of acute dissection. Although ran-
omized trials have not been conducted, the available data
uggest that among those with vascular complication of type
II aortic dissection, the early mortality is considerably lower
or stent-grafting than for open repair (8).
Still unknown, however, is whether or not prophylactic
tent-grafting can reduce the risk of late surgery or death
mong patients with initially uncomplicated distal aortic
issection. The mechanisms by which stent-grafting might
mprove late outcomes is hypothesized to be as follows: the
tent-graft is deployed in the proximal descending thoracic
orta, reapposing the dissected layers of the aorta and
overing over the site of intimal tear (entry site); this
revents blood flow into the false lumen, resulting in
ecompression and thrombosis of the false lumen, which
hould be favorable as numerous reports have found that a
hrombosed false lumen predicts lower aortic event rates
4,9) and a reduction in aortic diameter (5). Additionally,
overing over the intimal tear could potentially reduce the
isk of retrograde extension of a type III aortic dissection
nto the ascending aorta.
But stent-grafting is not without risks. In a recent
eta-analysis of 39 studies involving 609 patients with
istal dissection treated with stent-grafts, major complica-
ions occurred in 11%, with stroke or paraplegia in 3% (8).
oreover, the complication rate rose to 21% when treating
cute rather than chronic dissection. A recently completed
andomized European trial (INSTEAD [INvestigation of
TEnt grafts in patients with type B Aortic Dissection])
as designed to compare the 2-year outcome of endovas-
ular stenting versus medical therapy for uncomplicated
ubacute and chronic (2 weeks to 12 months) type III cissection (10). The preliminary trial results revealed that,
urprisingly, there was no survival benefit from stent-
rafting after the first year of the 2-year follow-up (Dr. C.
ienaber, personal communication, March 2007). The lack
f benefit may be because the duration of follow-up is still
oo short, or perhaps it is related to the fact that the
rocedures were performed beyond the acute phase of the
ortic dissection, so the dissected aortas had lost the capacity
o remodel favorably. This limitation should be overcome by
nother soon-to-be-launched randomized prospective Eu-
opean trial, the ADSORB (Acute Dissection Stent-
rafting Or Best Medical Treatment) study, which will
nvestigate the impact of stent-grafting on uncomplicated
ype III aortic dissection in the acute phase.
Clearly, while endovascular stent-grafting still holds the
romise of improved long-term outcomes for uncompli-
ated distal aortic dissection, that promise has yet to be
ealized. Indeed, before one considers routine use of stent-
rafts in patients with uncomplicated type III aortic dissec-
ion, one must recognize that, per the mortality data above,
he majority of patients actually fare quite well with medical
herapy alone. Consequently, identifying a population of
atients with distal dissection that may benefit from pro-
hylactic stent-grafting requires improved methods of risk
tratification.
Some clinical predictors of increased risk include Marfan
yndrome, female gender, history of atherosclerosis or a
rior aortic aneurysm, and the presence of pleural effusion
4). A number of anatomic features of the dissected aorta
ave also been found to be predictive of increased risk: a
atent false lumen (3); those with a maximal aortic diameter
f 4 cm at presentation (3,5); and those who have an
ntramural hematoma with localized dissection and/or
lcer-like projections on CT scan. Conversely, those with
ure intramural hematoma and no evident communication
ith the aortic lumen are at very low risk (5).
A recent report from Immer et al. (11) concluded that a
arge false lumen was the strongest predictor of distal aortic
xpansion among patients with chronic type I aortic dissec-
ion. However, these investigators identified a large false
umen by measuring the cross-sectional area of the false
umen divided by the area of the whole aorta (both lumens)
t that level, to provide a ratio. They concluded that a ratio
f 0.7 is predictive of progressive aortic enlargement.
lthough their findings are provocative, this method of
izing the false lumen is cumbersome in clinical practice.
ortunately, Song et al. (1) have now proposed a simpler
ethod of measuring false lumen size that is a powerful
redictor of future aneurysm development. Since clinicians
an measure such false lumen diameters on standard work-
tations, the method could be widely adopted and routinely
eported.
In conclusion, among patients with acute distal aortic
issection, the finding of a large false lumen diameter may
dentify a high-risk group in whom prophylactic stent-grafting
ould prove beneficial. Indeed, since as of this writing enroll-
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August 21, 2007:805–7 Editorial Commentent in the ADSORB trial has not yet commenced, it may be
rudent for the investigators to add to their protocol, prospec-
ively, a subgroup analysis that compares outcomes of those
ith false lumen diameters of 21 mm versus 22 mm.
oing so would maximize the likelihood that this pivotal trial
ill succeed in identifying, at the very least, a subgroup of acute
istal aortic dissection patients that significantly benefit from
rophylactic aortic stent-grafting.
eprint requests and correspondence: Dr. Eric M. Isselbacher,
horacic Aortic Center, Massachusetts General Hospital, YAW-
800, 55 Fruit Street, Boston, Massachusetts 02114. E-mail:
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